[
    {
        "title": "Little Excitement Around SCYNEXIS, Inc.'s (NASDAQ:SCYX) Revenues As Shares Take 28% Pounding - Simply Wall St",
        "description": "Little Excitement Around SCYNEXIS, Inc.'s (NASDAQ:SCYX) Revenues As Shares Take 28% Pounding  Simply Wall St",
        "published date": "Tue, 26 Sep 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMijgFodHRwczovL3NpbXBseXdhbGwuc3Qvc3RvY2tzL3VzL3BoYXJtYWNldXRpY2Fscy1iaW90ZWNoL25hc2RhcS1zY3l4L3NjeW5leGlzL25ld3MvbGl0dGxlLWV4Y2l0ZW1lbnQtYXJvdW5kLXNjeW5leGlzLWluY3MtbmFzZGFxc2N5eC1yZXZlbnVlcy1h0gGSAWh0dHBzOi8vc2ltcGx5d2FsbC5zdC9zdG9ja3MvdXMvcGhhcm1hY2V1dGljYWxzLWJpb3RlY2gvbmFzZGFxLXNjeXgvc2N5bmV4aXMvbmV3cy9saXR0bGUtZXhjaXRlbWVudC1hcm91bmQtc2N5bmV4aXMtaW5jcy1uYXNkYXFzY3l4LXJldmVudWVzLWEvYW1w?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1"
    },
    {
        "title": "First Edition: Sept. 26, 2023 - KFF Health News",
        "description": "First Edition: Sept. 26, 2023  KFF Health News",
        "published date": "Tue, 26 Sep 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiRmh0dHBzOi8va2ZmaGVhbHRobmV3cy5vcmcvbW9ybmluZy1icmVha291dC9maXJzdC1lZGl0aW9uLXNlcHQtMjYtMjAyMy_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1"
    },
    {
        "title": "EVA Investors Have Opportunity to Lead Enviva Inc. Securities ... - PR Newswire",
        "description": "EVA Investors Have Opportunity to Lead Enviva Inc. Securities ...  PR Newswire",
        "published date": "Tue, 26 Sep 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiggFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2V2YS1pbnZlc3RvcnMtaGF2ZS1vcHBvcnR1bml0eS10by1sZWFkLWVudml2YS1pbmMtc2VjdXJpdGllcy1mcmF1ZC1sYXdzdWl0LTMwMTkzOTI4NC5odG1s0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1"
    },
    {
        "title": "Ocuphire Pharma Receives FDA Approval for RYZUMVI Type 3 New ... - Best Stocks",
        "description": "Ocuphire Pharma Receives FDA Approval for RYZUMVI Type 3 New ...  Best Stocks",
        "published date": "Tue, 26 Sep 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiRWh0dHBzOi8vYmVzdHN0b2Nrcy5jb20vb2N1cGhpcmUtcGhhcm1hLXJlY2VpdmVzLWZkYS1hcHByb3ZhbC1mb3Itcnl6L9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1"
    }
]